CIK 0000914475
- Large accelerated filer
NEUROCRINE BIOSCIENCES INC
Sign in to watch- Ticker
- NBIX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330525145
- Phone
- +1 858-617-7600
- Business address
- 6027 EDGEWOOD BEND COURT, SAN DIEGO, CA, 92130
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,162,347
- in 4 filings, $3.2M under 10b5-1 plans
Net −$3,162,347. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-07 | Cooke Julie Chief Human Resources Officer | Sale | −640 | $80.63 | $52K | 16,783 |
| 2022-02-07 | BENEVICH ERIC Chief Commercial Officer | Sale | −809 | $80.68 | $65K | 16,483 |
| 2022-02-07 | BENEVICH ERIC Chief Commercial Officer | Sale | −2,030 | $80.83 | $164K | 18,309 |
| 2022-02-07 | BENEVICH ERIC Chief Commercial Officer | Sale | −1,280 | $80.78 | $103K | 19,459 |
| 2022-02-07 | ABERNETHY MATT Chief Financial Officer | Sale | −2,030 | $80.80 | $164K | 18,175 |
| 2022-02-07 | ABERNETHY MATT Chief Financial Officer | Sale | −1,280 | $80.78 | $103K | 19,325 |
| 2022-01-31 | Lloyd-Smith Malcolm Chief Regulatory Officer | Grant or award · Stock Option | +21,546 | 21,546 | ||
| 2022-01-31 | Lloyd-Smith Malcolm Chief Regulatory Officer | Grant or award · Restricted Stock Unit | +3,164 | 3,164 | ||
| 2022-01-31 | Cooke Julie Chief Human Resources Officer | Grant or award · Stock Option | +47,401 | 47,401 | ||
| 2022-01-31 | Cooke Julie Chief Human Resources Officer | Grant or award · Restricted Stock Unit | +6,961 | 6,961 | ||
| 2022-01-31 | Grigoriadis Dimitri E. Chief Research Officer | Grant or award · Stock Option | +32,319 | 32,319 | ||
| 2022-01-31 | Grigoriadis Dimitri E. Chief Research Officer | Grant or award · Restricted Stock Unit | +4,746 | 4,746 | ||
| 2022-01-31 | Gano Kyle Chief Business Development Off | Grant or award · Stock Option | +79,720 | 79,720 | ||
| 2022-01-31 | Gano Kyle Chief Business Development Off | Grant or award · Restricted Stock Unit | +11,706 | 11,706 | ||
| 2022-01-31 | Lippoldt Darin Chief Legal Officer | Grant or award · Stock Option | +64,638 | 64,638 | ||
| 2022-01-31 | Lippoldt Darin Chief Legal Officer | Grant or award · Restricted Stock Unit | +9,492 | 9,492 | ||
| 2022-01-31 | BENEVICH ERIC Chief Commercial Officer | Grant or award · Stock Option | +62,483 | 62,483 | ||
| 2022-01-31 | BENEVICH ERIC Chief Commercial Officer | Grant or award · Restricted Stock Unit | +9,175 | 9,175 | ||
| 2022-01-31 | Onyia Jude Chief Scientific Officer | Grant or award · Stock Option | +6,464 | 6,464 | ||
| 2022-01-31 | Onyia Jude Chief Scientific Officer | Grant or award · Restricted Stock Unit | +950 | 950 |
Page 56 of 62 · 1,221 trades